Aiming to get a foothold in the emerging clinical next-gen sequencing market in Europe, GATC Biotech of Germany earlier this month launched a one-week diagnostic exome sequencing service designed to "meet the varied requirements of clinicians."

While the company performs the service worldwide under the European EN ISO/IEC 17025 standard, which it says is similar to the CLIA laboratory standards in the US, it does not currently provide clinical interpretation of the results, which it plans to add in the future.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.